Scholars International Conference on
STD, HIV and AIDS Research
THEME: "Transcending Barriers, Creating Opportunities"
18-19 Nov 2019 
Radisson Narita, Tokyo, Japan THEME: "Transcending Barriers, Creating Opportunities"
18-19 Nov 2019
Radisson Narita, Tokyo, Japan 
Yokohama University of Pharmacy, Japan
Title: EFdA: A very excellent anti-HIV modified nucleoside?- From design to the current clinical trial results
Dr. Hiroshi Ohrui has completed his PhD in Organic Chemistry at the University of Tokyo and postdoctral studies at Sloan-Ketterng Institute for Cancer Research and Syntex Resaerch. He has worked for both Riken and Tohoku University, and received several awards including The Japan Society for Analytical Chemistry Award and Japan Academy Prize.
Hiroshi Ohrui Resesarch includes organic synthesis, chemical biology, and chiral discrimination.